Health care stocks rose late Friday afternoon, with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%.
The iShares Biotechnology ETF (IBB) was 0.9% higher.
In corporate news, BioXcel Therapeutics (BTAI) shares jumped 24% after the company regained compliance with Nasdaq's minimum closing bid price rule.
Owens & Minor (OMI) shares surged 40% after it reported better-than-expected quarterly results and a share buyback plan Friday.
DocGo (DCGO) shares fell past 21% after the company reported a Q4 net loss, surprising analysts who expected a profit.
Praxis Precision Medicines (PRAX) shares dropped 41%. An independent data monitoring committee overseeing the company's study 1 of the Essential3 program of ulixacaltamide in essential tremor recommended that the study be "stopped for futility."
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。